Balchem Corporation
Rank #327HypergrowthBCPC · Nasdaq · Basic Materials
Balchem Corporation (BCPC) — Rank #327 by gross profitability (GP/assets 0.22) · ROE 11.9% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0000009326 · all metrics point-in-time as of the filing date.
About
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Show moreShow less
It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents.
The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- State
- MD
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- balchem.com
Price History
Company Snapshot
P/S is the primary valuation lens — earnings are reinvested, not available for P/E.
Market Cap
$5.24B
P/E (annual)
34.6
P/S (annual)
5.1
P/B
4.0
P/OCF (annual)
24.2
Shareholder Yield
0.2%
Employees
1,379
Industry
Specialty Chemicals
Exchange
Nasdaq
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
3/3 passGrowth
2/2 passTerry Smith quality gate
Passes 2/5 Terry Smith thresholds1 of 5 threshold not computable from filed data.
What Growth Is Priced In
Implied revenue growth (10Y)
13.7%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Dilution drag: 0.3% — per-share value needs a total required return of 14.0% once share-count change is priced in.
vs. own 6-year median revenue growth: 7.9%
priced above its own historyCost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
9.0%
r = 10% (base)
13.7%
r = 12%
17.7%
Net debt / market cap: -1.2%
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.
Profitability
Gross profitability (GP / assets)
0.22
Primary signal (Novy-Marx).
45th pctl of 34 SIC 28 peers
Return on equity
11.9%
Gross margin
35.7%
33rd pctl of 34 SIC 28 peers
Revenue growth (YoY)
47.4%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
Earnings CAGR (3Y)
13.7%
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.30
87th pctl of 31 SIC 28 peers (best = lowest)
Current ratio
2.66×
61st pctl of 34 SIC 28 peers
Quick ratio
1.46×
Net cash
$63.17M
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
$173.07M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
0.12
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
1.7%
Stock-based comp intensity.
Dividend safety
Composite score
4.2 / 5
Piotroski F-Score
F-Score
N/A
Only 8/9 components determinable.